Talking the Whiz Quiz: An HR Guide to Drug Testing
In this episode of Talking the Whiz Quiz, Lori and Gary Oshman of AZC Drug Testing discuss important DOT drug and alcohol testing updates for employers, HR teams, owner-operators, and safety-sensitive workplaces.Gary shares key takeaways from the 2026 NDASA conference, including FMCSA Clearinghouse identity verification changes, concerns around fraudulent Substance Abuse Professionals, the current status of DOT oral fluid testing, and the proposed addition of fentanyl to DOT drug testing panels.AZC Drug Testing is also celebrating 30 years in business, with services including drug testing, alcohol testing, background checks, fingerprinting, mobile testing, C/TPA support, and employer compliance assistance.Topics covered:0:10 - Welcome and AZC Drug Testing’s 30-year anniversary2:01 - What this episode covers2:36 - What NDASA is and why the conference matters5:55 - FMCSA Clearinghouse identity verification updates8:55 - Why SAP fraud creates safety and compliance concerns11:12 - How new identity checks may affect employers, drivers, and C/TPAs14:52 - Clearinghouse query credit challenges for owner-operators and small companies16:44 - Current status of DOT oral fluid drug testing20:17 - Proposed changes related to FDA clearance requirements21:51 - What future testing methods, including hair testing, could mean for employers24:43 - Proposed fentanyl testing updates for DOT drug testing panels26:53 - Why fentanyl does not currently show up unless specifically tested for29:50 - How DOT fentanyl testing could impact non-regulated drug testing costs31:09 - Final thoughts and future AZC Drug Testing updatesLearn more about AZC Drug Testing:https://azcdt.com/
9 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Talking the Whiz Quiz: An HR Guide to Drug Testing!